Tuesday, 5 May 2020

Alembic Pharma's Panelav plant receives VAI from USFDA

US Food and Drug Administration (USFDA) has classified the Alembic Pharmaceuticals General Oral Solid Formulation Facility located at Panelav as Voluntary Action Indicated (VAI).



source https://www.pharmatutor.org/pharma-news/2020/alembic-pharma-panelav-plant-receives-vai-from-usfda

No comments:

Post a Comment

Pharmaceutical Industry and pharma / Life Sciences institute openings 2025

  Intas Pharma Walk in Drive for M.Pharm, B.Pharm | Multiple Posts M.Pharma / B.Pharma. Injectable/Parenteral/Sterile - Aseptic, Manufacturi...